Ref ID: 18769
Author:
S. Sahli, MS – MS 1, S. Boulahfa, MS – MS 1, M. Cornet, MD (Doctor of Medicine) – Professor1,2;
Author address:
1Université Joseph Fourier, Grenoble, France, 2CHU, Grenoble, France.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: The role of the pH regulation in antifungal activity was suggested when the azole compound D0870 showed enhanced fungicidal effect against C. neoformans at low pH. Later, azoles susceptibility tests in Candida sp. showed an inhibition of the trailing effect under acidic conditions. pH regulation in yeasts is mainly controlled by the Rim pathway: a cascade of seven proteins triggered at neutral-alkaline pH and inactivated in acidic conditions. Methods: We analyzed the susceptibility of six C. albicans rim deleted strains and a control strain (DAY286) to the triazoles, other ergosterol synthesis inhibitors (terbinafine, fenpropimorph) and amphotericin B. MICs were determined using the M27-A3 CLSI microdilution method. Results are means calculated from at least 10 independent experiments. Cidality assays were performed using the cells from the MIC assays that were spotted onto rich and solid medium without any antifungal compounds. Results: All the rim mutants showed significant reduction of the MICs to all the ergosterol synthesis inhibitors other than terbinafine (Table 1). On spotted assays, the control strain was able to grow after exposure to all concentrations of all the ergosterol synthesis inhibitors. Rim inhibition in all mutants enhanced cidality of all the ergosterol synthesis inhibitors except terbinafine, with the more severe effect for the triazoles. Interestingly, amphotericin B which independently targets the ergosterol of the membrane, most probably through a mechanical interaction, showed conserved activity in the rim deleted strains.
Conclusions: Our results support the hypothesis that targeting the Rim pH signaling pathway may constitute a novel approach to enhance fungal inhibition and killing.
Abstract Number: M-983
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a